1 Min Read
LONDON, May 12 (Reuters) - High-profile British fund manager Neil Woodford said on Friday he had sold out of pharmaceutical company GlaxoSmithKline after holding shares in the company for more than 15 years.
In a strongly worded blog post on the firm's website entitled 'Glaxit', Woodford said the firm had a weak pipeline of new drugs and a lack of strategic options, which made him less convinced that the dividend was sustainable.
While he had spoke to management regularly over the years and argued for a break-up of the company into separate, more specialised business units, he said the prospect "now looks more remote than ever". (Reporting by Simon Jessop; editing by Carolyn Cohn)